BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37075587)

  • 1. TERT promoter mutations in head and neck squamous cell carcinoma: A systematic review and meta-analysis on prevalence and prognostic significance.
    Boscolo-Rizzo P; Tirelli G; Polesel J; Sia E; Phillips V; Borsetto D; De Rossi A; Giunco S
    Oral Oncol; 2023 May; 140():106398. PubMed ID: 37075587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.
    Boscolo-Rizzo P; Giunco S; Rampazzo E; Brutti M; Spinato G; Menegaldo A; Stellin M; Mantovani M; Bandolin L; Rossi M; Del Mistro A; Tirelli G; Dei Tos AP; Guerriero A; Niero M; Da Mosto MC; Polesel J; De Rossi A
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):381-389. PubMed ID: 31960186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas.
    Vinothkumar V; Arunkumar G; Revathidevi S; Arun K; Manikandan M; Rao AK; Rajkumar KS; Ajay C; Rajaraman R; Ramani R; Murugan AK; Munirajan AK
    Tumour Biol; 2016 Jun; 37(6):7907-13. PubMed ID: 26700669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma.
    Chang KP; Wang CI; Pickering CR; Huang Y; Tsai CN; Tsang NM; Kao HK; Cheng MH; Myers JN
    Head Neck; 2017 Jun; 39(6):1131-1137. PubMed ID: 28230921
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Yu Y; Fan D; Song X; Zakeri K; Chen L; Kang J; McBride S; Tsai CJ; Dunn L; Sherman E; Katabi N; Dogan S; Cracchiolo J; Cohen M; Boyle JO; Lee M; Valero C; Wang J; Wong R; Morris L; Riaz N; Lee N
    JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34381934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.
    Annunziata C; Pezzuto F; Greggi S; Ionna F; Losito S; Botti G; Buonaguro L; Buonaguro FM; Tornesello ML
    Int J Cancer; 2018 Sep; 143(5):1153-1161. PubMed ID: 29603728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter region mutations of the telomerase reverse transcriptase (TERT) gene in head and neck squamous cell carcinoma.
    Yilmaz I; Erkul BE; Ozturk Sari S; Issin G; Tural E; Terzi Kaya Terzi N; Karatay H; Celik M; Ulusan M; Bilgic B
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Jul; 130(1):63-70. PubMed ID: 32404253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.
    Mohtasham N; Najafi-Ghobadi K; Abbaszadeh H
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1776. PubMed ID: 36573562
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Arantes LMRB; Cruvinel-Carloni A; de Carvalho AC; Sorroche BP; Carvalho AL; Scapulatempo-Neto C; Reis RM
    Front Oncol; 2020; 10():1275. PubMed ID: 32850388
    [No Abstract]   [Full Text] [Related]  

  • 10. TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas.
    Saito Y; Kage H; Kobayashi K; Yoshida M; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
    Head Neck; 2023 Dec; 45(12):3107-3118. PubMed ID: 37815002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
    J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Telomerase Reverse Transcriptase Promoter Mutations with the Prognosis of Glioma Patients: a Meta-Analysis.
    Wang X; Li X; Xu F; Zhang Y; Liu H; Tao Y
    Mol Neurobiol; 2016 May; 53(4):2726-32. PubMed ID: 26351078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data.
    Vuong HG; Altibi AMA; Duong UNP; Ngo HTT; Pham TQ; Chan AK; Park CK; Fung KM; Hassell L
    Crit Rev Oncol Hematol; 2017 Dec; 120():1-9. PubMed ID: 29198322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.
    Zhou LQ; Hu Y; Xiao HJ
    BMC Cancer; 2021 Apr; 21(1):424. PubMed ID: 33863308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Giunco S; Boscolo-Rizzo P; Rampazzo E; Tirelli G; Alessandrini L; Di Carlo R; Rossi M; Nicolai P; Menegaldo A; Carraro V; Tofanelli M; Bandolin L; Spinato G; Emanuelli E; Mantovani M; Stellin M; Bussani R; Dei Tos AP; Guido M; Morello M; Fussey J; Esposito G; Polesel J; De Rossi A
    Front Oncol; 2021; 11():782658. PubMed ID: 34858860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance of TERT promoter mutation in papillary thyroid carcinomas: a systematic review and meta-analysis.
    Yin DT; Yu K; Lu RQ; Li X; Xu J; Lei M; Li H; Wang Y; Liu Z
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):299-305. PubMed ID: 26732020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Coexistent BRAF
    Moon S; Song YS; Kim YA; Lim JA; Cho SW; Moon JH; Hahn S; Park DJ; Park YJ
    Thyroid; 2017 May; 27(5):651-660. PubMed ID: 28181854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
    Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
    Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.